New data with longer-term follow-up suggest that PSA screening probably lowers prostate cancer mortality — but experts stress ...

(HealthDay News) — Prostate-specific antigen (PSA) screening likely results in a reduction in prostate cancer-specific mortality, according to a review published online May 15 in the Cochrane Database ...

Prostate cancer incidence is increasing, especially in advanced stages, reversing previous declines and slowing mortality rate improvements. Racial disparities persist, with Black and Native American ...

Treatment holiday for patients with metastatic hormone sensitive prostate cancer: Real-world experience at a single center. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This ...

About The Study: In this study, dropping the cancer label from grade group (GG)1 prostate disease and redefining GG1 prostate disease as a precancerous lesion led to a net reduction in estimated ...

What are the current prostate cancer screening guidelines and treatment recommendations? Men may be offered prostate cancer screening at different life stages depending on their individual risk. Age, ...

Symptoms linked to urinary or sexual health often carry an element of embarrassment, making men less likely to discuss them ...

Here in the United States, prostate cancer is the second most diagnosed cancer in men, behind only skin cancer. Almost 13% of ...

Staging means finding out how far prostate cancer has spread in your body. Physicians group prostate cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being ...

Prostate cancer is the most common cancer among men after skin cancer. Age is a significant risk factor for prostate cancer. Family history and genetic factors play a significant role in prostate ...